CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
The Long-term Clinical Results of a Platelet Glycoprotein IIb/IIIa Receptor Blocker Abciximab: ReoProR Coated Stent in Patients with Coronary Artery Disease
Weon Kim, Myung Ho Jeong, Young Joon Hong, Seng Hyun Lee, Woo Seok Park, Ju Han Kim, In Soo Kim, Myung Ja Choi, Young Keun Ahn, Jeong Gwan Cho, Jong Chun Park, Dong Lyun Cho, Hoon Kim
Korean J Intern Med. 2004;19(4):220-229.   Published online 2004 December 1    DOI: https://doi.org/10.3904/kjim.2004.19.4.220

Excel Download

1139-53 The long-term clinical results of a platelet glycoprotein IIb/IIIa receptor blocker (Abciximab: ReoPro®) coated stent in patients with coronary artery disease
Journal of the American College of Cardiology. 2004;43(5):A84   Crossref logo
Link1 Link2

Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial
The Lancet. 2001;357(9272):1915-1924   Crossref logo
Link1 Link2

Glycoprotein IIb/IIIa platelet receptor blockers: Are they ready for prime time in patients with unstable coronary artery disease?
Clinical Cardiology. 1999;22(2):57-58   Crossref logo
Link1 Link2

The impact of three different glycoprotein platelet receptor IIb/IIIa antagonists on glycoprotein IIb/IIIa platelet receptor inhibition and clinical endpoints in patients with acute coronary syndromes
Heart, Lung and Circulation. 2015;24:S168   Crossref logo
Link1 Link2

Platelet glycoprotein IIb/IIIa—receptor inhibitors in patients with acute coronary syndromes or undergoing percutaneous coronary interventions: a review
Clinical Therapeutics. 2001;23(8):1145-1165   Crossref logo
Link1 Link2

Abciximab: platelet IIb/IIIa receptor blockade in the management of patients with acute coronary syndromes
Coronary Health Care. 1998;2(1):2-10   Crossref logo
Link1 Link2

The Clinical Results of a Platelet Glycoprotein IIb/IIIa Receptor Blocker (Abciximab: ReoPro)-Coated Stent in Acute Myocardial Infarction
Journal of the American College of Cardiology. 2006;47(5):933-938   Crossref logo
Link1 Link2

Platelet glycoprotein IIb/IIIa receptor antagonists and coronary artery disease
Current Atherosclerosis Reports. 2001;3(2):139-148   Crossref logo
Link1 Link2 Link3

Anti-platelet therapy: glycoprotein IIb-IIIa antagonists
British Journal of Clinical Pharmacology. 2011;72(4):672-682   Crossref logo
Link1

The Long-Term Clinical Results of a Platelet Glycoprotein IIb/IIIa Receptor Blocker (Abciximab : ReoPro®) Coated Stent in Patients with Acute Myocardial Infarction
Korean Circulation Journal. 2004;34(11):1063   Crossref logo
Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Korean J Intern Med has participated in CrossRef Text and Data Mining service since August 31, 2015.